Over 15 lakh people inoculated against COVID-19 in India; world leaders laud New Delhi's 'vaccine diplomacy'

-

On Saturday the number of Indians inoculated with the first dose of coronavirus vaccine crossed 15 lakh, with 3,47,058 vaccinated within the last 24 hours, the health ministry said. Meanwhile, the number of people who have tested positive for the UK variant of COVID-19 in India climbed up to 150 while the total number of active cases stood at 1.85 lakh.

India also received praise and words of gratitude from world leaders for supplying coronavirus vaccines to other countries, despite having a large population to cater to at home.

WHO chief Tedros Adhanom Ghebreyesus also thanked Prime Minister Narendra Modi for his continued support to the global COVID-19 response, saying acting together, including sharing of knowledge, will help in combating the novel coronavirus.

Nearly 14 lakh beneficiaries inoculated; active caseload around 1,85,000

According to data released by the Union Health Ministry, the highest number of 1,84,699 vaccinations in the country has been reported from Karnataka, followed by Andhra Pradesh (1,33,298), Odisha (1,30,007), and Uttar Pradesh (1,23,761).

As many as 1,10,031 beneficiaries were inoculated in Telangana, 74,960 in Maharashtra, 63,620 in Bihar, 62,142 in Haryana, 47,293 in Kerala, and 38,278 in Madhya Pradesh, according to the data.

In a statement, the ministry said in the last 24 hours, 3,47,058 people were vaccinated in 6,241 sessions and 27,776 such sessions have been conducted across the country so far.

"As on 23 January, 2021, till 8 am, nearly 14 lakh (13,90,592) beneficiaries have received the vaccination under the countrywide COVID19 vaccination exercise," it said.

India's active COVID-19 caseload continued to manifest a downward movement and dropped to 1,85,662 on Saturday.

"India's present active caseload now consists of just 1.74 percent of India's total positive cases," the ministry said.

It added that 28 states and Union territories in the country have less than 5,000 active coronavirus cases each and their recovery rate is above the national average.

The country's total caseload has mounted to 1,06,39,684 and the death toll due to the viral disease has climbed to 1,53,184 with 152 people succumbing to it in a span of 24 hours, the data showed.

150 people infected with UK variant of COVID-19 in India

The number of people who have tested positive for the UK variant of COVID-19 in India has climbed to 150, the Union Health Ministry said on Saturday.

All of them have been kept in single room isolation in designated health care facilities by the respective state governments, the ministry had said earlier.

Their close contacts have also been put under quarantine. Comprehensive contact tracing has been initiated for co-travellers, family contacts, and others.
Genome sequencing on other specimens is going on, the ministry said.

The situation is under careful watch and regular advice is being provided to the states for enhanced surveillance, containment, testing and dispatch of samples to INSACOG (Indian SARS-CoV-2 Genomics Consortium) labs.

WHO chief, Brazil president thank Modi; US praises India for vaccine supply

"Thank you, India and Prime Minister Narendra Modi for your continued support to global COVID-19 response. Only if we act together, including sharing of knowledge, can we stop this virus and save lives and livelihoods," tweeted Ghebreyesus, the Director-General of the World Health Organisation.

Prime Minister Modi has said India's vaccine production and delivery capacity will be used for the benefit of all humanity to fight the COVID-19 pandemic. Last week, he had said that India was ready to do everything possible for a healthy planet.

Brazilian president Jair Bolsonaro also thanked India after his country received a consignment of 20 lakh doses of COVID-19 vaccines.  Tweeting an image of Hindu god Hanuman carrying a mountain of coronavirus vaccine to Brazil, Bolsonaro thanked India for helping his country with the jabs.

Terming India a "true friend" which is using its pharmaceutical sector to help the global community, the US has applauded New Delhi for gifting COVID-19 vaccines to several countries.

In the last few days, India has sent consignments of domestically produced coronavirus vaccines under grant assistance to Bhutan, Maldives, Nepal, Bangladesh, Myanmar, Mauritius, and Seychelles. It is also undertaking commercial supplies of the doses to a number of countries, including Saudi Arabia, South Africa, Brazil, and Morocco.

"We applaud India's role in global health, sharing millions of doses of COVID-19 vaccine in South Asia. India's free shipments of the vaccine began with Maldives, Bhutan, Bangladesh, and Nepal and will extend to others," the South and Central Asia Bureau of the US State Department tweeted on Friday.

"India's a true friend using its pharma to help the global community," it said.

Known as the 'pharmacy of the world', India produces 60 percent of vaccines globally.

House Foreign Affairs Committee Chairman Gregory Meeks also commended India's support to its neighbouring countries to fight the pandemic.

"I commend India's efforts to help its neighbours by providing them with free COVID-19 vaccines. Global challenges like the pandemic require both regional and global solutions," Meeks said.

The US media also praised India's support to the global community in this health crisis.

According to a Washington Post report, India is giving away millions of coronavirus vaccine doses as a tool of diplomacy.

"The Indian government has sent free doses to Bangladesh, Nepal, Bhutan, and the Maldives more than 3.2 million in total. Donations to Mauritius, Myanmar, and Seychelles are set to follow. Sri Lanka and Afghanistan are next on the list," it noted.

"The shipments reflect one of India's unique strengths: It is home to a robust vaccine industry, including Serum Institute of India, one of the world's largest vaccine makers," the report said.

With inputs from PTI



from Firstpost India Latest News https://ift.tt/2LXiHXa
FP Staff

Comments

Post a Comment

Popular posts from this blog

Both COVID-19 vaccine doses needed for good protection against B16172 variant

-
It’s been a concerning few weeks in the UK, with the B16172 variant first taking hold and then spreading to become dominant. This more infectious form of the virus, initially identified in India, is what we’re now going to have to live with – unless it is out-competed by another variant in the future. Worryingly, experts had predicted that B16172 might be able to escape some of the effects of vaccines, which if true would threaten to derail the UK’s plans to finish lifting restrictions from the end of June. However, Public Health England (PHE) has looked at the ability of various variants to evade immunity and says that the UK’s vaccines remain effective against the variants circulating, including B16172. On the surface, this looks like good news. But delve a bit deeper, and things get more complicated, says Paul Hunter, professor of medicine at the University of East Anglia. PHE’s research found a little drop-off in protection against B16172 among people who were fully vaccinated.
Read more

New coronavirus variant emerge in India: How should our COVID response change?

-
Image
After genome sequencing of over 10,000 COVID-19 cases in India, researchers have discovered a new variant with two new mutations which may be better at evading the immune system. In 15-20 percent of samples from the Indian state of Maharashtra (the state accounting for 62 percent of cases in the country) a new, double mutation in key areas of the virus has been detected. These are now known as the E484Q and L452R mutations. What makes the variant different? Both these mutations are concerning because they are located in a key portion of the virus – the spike protein – that it uses to penetrate human cells. Spike proteins attach via a “receptor binding domain”, meaning the virus can attach to receptors in our cells. These new mutations include changes to the spike protein that make it a “better fit” for human cells. This means the virus can gain entry more easily and multiply faster. Given what we have seen with other similar mutations , it might also make it harder for our immu
Read more

Aditya L1 Mission: Spacecraft is nearing its final phase, says ISRO chief

-
Aditya L1 spacecraft is nearing its final phase, and manoeuvres to enter the L1 point are expected to be completed by January 7, 2024, according to ISRO Chairman S Somanath. “Aditya is on the way. I think it has reached almost its final phase,” the ISRO chief told PTI on the sidelines of an event organised at VSSC to commemorate the 60th year of the First Sounding Rocket Launch. Aditya L1, India’s first space-based mission to study the Sun, was successfully launched on September 2 from the Satish Dhawan Space Centre (SDSC) in Sriharikota. The spacecraft, after travelling about 1.5 million km from Earth over 125 days, is expected to be placed in a Halo orbit around the Lagrangian point L1, considered closest to the Sun. He said that the last preparations for the spacecraft’s entry into the L1 point are currently underway incrementally.”Possibly by January 7th, the final manoeuvres will be done for entering into the L1 point,” Somanath added. Among other tasks, it will capture and tr
Read more